Optimism for Biocon is fuelled by the green light for its Bengaluru biologics unit, paired with the USFDA approval for the launch of its Stelara biosimilar for autoimmune disorders, ...
Biocon Biologics completes one-year as an integrated global biosimilars enterprise: Our Bureau, Bengaluru Wednesday, January 8, 2025, 11:30 Hrs [IST] Biocon Biologics in its first ...